Insider · CIK 0001821198
Jared Gollob
Files at KYMR (Kymera Therapeutics, Inc.). First filing Mar 3, 2025, latest Mar 3, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KYMR: Kymera Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Kymera Therapeutics, Inc. | $175k 5,740 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 125,740 | Mar 3, 2025 |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock | -4,695 | $30.33 | $142k | 121,045 | Mar 3, 2025 |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock | -1,045 | $31.00 | $32k | 120,000 | Mar 3, 2025 |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Mar 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.